Characteristics and Outcomes of Myelodysplastic Syndrome Patients Treated With Darbepoetin Alfa for Anemia in Turkey: A Multicenter Retrospective Study

被引：0
|
作者：
Acar, Ibrahim Halil [1 ]
Atalay, Figen [2 ]
Demirsoy, Esra Terzi [3 ]
Can, Ferda [4 ]
Guven, Zeynep Tugba [5 ]
Cetiner, Mustafa [6 ]
Tombak, Anil [7 ]
Comert, Melda [8 ]
Guvenc, Birol [1 ]
机构：
[1] Cukurova Univ, Dept Hematol, Dept Internal Med, Fac Med, Adana, Turkiye
[2] Baskent Univ, Istanbul Hosp, Hematol Clin, Ankara, Turkiye
[3] SBU Kocaeli Derince Training & Res Hosp, Hematol Clin, Kocaeli, Turkiye
[4] Ankara City Hosp, Hematol Clin, Ankara, Turkiye
[5] Erciyes Univ, Dept Hematol, Dept Internal Med, Fac Med, Kayseri, Turkiye
[6] Acibadem Maslak Hosp, Hematol Clin, Istanbul, Turkiye
[7] Mersin Univ, Dept Hematol, Dept Internal Med, Fac Med, Mersin, Turkiye
[8] SBU Gulhane Training & Res Hosp, Hematol Clin, Istanbul, Turkiye
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
MDS; myelodysplastic syndrome; darbepoetin alfa;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MDS-143
引用
收藏
页码：S354 / S354
页数：1
相关论文
共 50 条
  • [41] Comparison of Demographics, Disease Characteristics and Outcomes Between Black and White Patients With Myelodysplastic Syndrome: A Population-Based Study
    Lesegretain, Arnaud
    Laadem, Abderrahmane
    Fell, Geoffrey
    Fathi, Amir T.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S322 - S322
  • [42] Assessment of the International Prognostic Scoring System for determining chemotherapeutic indications in myelodysplastic syndrome: Japanese retrospective multicenter study
    Ito, Y
    Ohyashiki, K
    Hirai, H
    Ogawa, S
    Mitani, K
    Hotta, T
    Bessho, M
    Naoe, T
    Mizoguchi, H
    Uchiyama, T
    Omine, M
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2005, 82 (03) : 236 - 242
  • [43] The management and outcomes of patients with myelodysplastic syndrome with persistent severe thrombocytopenia: An observational single centre registry study
    Vijenthira, Abi
    Premkumar, Devyani
    Callum, Jeannie
    Lin, Yulia
    Wells, Richard A.
    Chodirker, Lisa
    Lenis, Martha
    Mamedov, Alexandre
    Buckstein, Rena
    LEUKEMIA RESEARCH, 2019, 76 : 76 - 81
  • [44] Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan
    Akizawa, Tadao
    Iwasaki, Manabu
    Yamaguchi, Yusuke
    Majikawa, Yoshikatsu
    Reusch, Michael
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 31 (07): : 1628 - 1639
  • [45] A prospective, multicenter, observational study of long-term decitabine treatment in patients with myelodysplastic syndrome
    Jeong, Seong Hyun
    Kim, Yoo-Jin
    Lee, Je-Hwan
    Kim, Yeo-Kyeoung
    Kim, Soo Jeong
    Park, Sung Kyu
    Do, Young Rok
    Kim, Inho
    Mun, Yeung-Chul
    Kim, Hoon Gu
    Lee, Won Sik
    Yi, Hyeon Gyu
    Joo, Young-Don
    Choi, Chul Won
    Kim, Suk Ran
    Na, Sang Min
    Jang, Jun Ho
    ONCOTARGET, 2015, 6 (42) : 44985 - 44994
  • [46] Androgen therapy for patients with lower-risk myelodysplastic syndrome and significant cytopenia: a retrospective study
    Choi, Eun-Ji
    Lee, Je-Hwan
    Park, Han-Seung
    Lee, Jung-Hee
    Seol, Miee
    Lee, Young-Shin
    Kang, Young-Ah
    Jeon, Mijin
    Woo, Ji Min
    Kang, Hyeran
    Lee, Kyoo-Hyung
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 187 (01) : E4 - E7
  • [47] Hidden myelodysplastic syndrome (MDS): A prospective study to confirm or exclude MDS in patients with anemia of uncertain etiology
    Maria Bastida, Jose
    Lopez-Godino, Oriana
    Vicente-Sanchez, Ana
    Bonanad-Boix, Santiago
    Xicoy-Cirici, Blanca
    Hernandez-Sanchez, Jesus M.
    Such, Esperanza
    Cervera, Jose
    Caballero-Berrocal, Juan C.
    Lopez-Cadenas, Felix
    Arnao-Herraiz, Mario
    Rodriguez, Ines
    Llopis-Calatayud, Inmaculada
    Jimenez, Maria J.
    Consuelo del Canizo-Roldan, Maria
    Diez-Campelo, Maria
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2019, 41 (01) : 109 - 117
  • [48] Preservation of Anemia Control and Weekly ESA Dosage After Conversion from PEG-Epoetin Beta to Darbepoetin Alfa in Adult Hemodialysis Patients: The TRANSFORM Study
    Jan Donck
    Lourdes Gonzalez-Tabares
    Jacques Chanliau
    Heike Martin
    Kyriaki Stamatelou
    Nick Manamley
    Mourad Farouk
    Janet Addison
    Advances in Therapy, 2014, 31 : 1155 - 1168
  • [49] Preservation of Anemia Control and Weekly ESA Dosage After Conversion from PEG-Epoetin Beta to Darbepoetin Alfa in Adult Hemodialysis Patients: The TRANSFORM Study
    Donck, Jan
    Gonzalez-Tabares, Lourdes
    Chanliau, Jacques
    Martin, Heike
    Stamatelou, Kyriaki
    Manamley, Nick
    Farouk, Mourad
    Addison, Janet
    ADVANCES IN THERAPY, 2014, 31 (11) : 1155 - 1168
  • [50] Characteristics and outcomes of children, adolescent, and young adult patients with myelodysplastic neoplasms: A single-center retrospective analysis
    McCall, David
    Abuasab, Tareq
    Rodriguez-Sevilla, Juan Jose
    Mohamed, Shehab Fareed
    Patnaik, Anish
    Devireddy, Kirthi
    Arani, Naszrin
    Sheikh, Irtiza
    Jamshidi, Raehannah
    Gibson, Amber
    Roth, Michael
    Nunez, Cesar
    Garcia, Miriam
    Chien, Kelly S.
    Loghavi, Sanam
    Pierce, Sherry A.
    Sasaki, Koji
    Issa, Ghayas
    Cuglievan, Branko
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    LEUKEMIA RESEARCH, 2024, 144
12345